BridgeMD
New treatment option for Opioid Dependence
Official title The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
ClinicalTrials.gov ID: NCT06837662
What this study is testing
- What it's testing
- The goal of this pilot clinical trial is to learn if a community informed designed program of addiction counseling with coordinated community peer navigator for people with Opioid Use Disorder (OUD) and other medical conditions can improve engagement in primary care and retention on buprenorphine. The main questions it aims to answer are: Does the addition of a counseling and peer referral interventions in addition to usual primary care with low-threshold buprenorphine increase retention on medications for opioid use disorder?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligibility/. For Aim 3, criteria we seek to recruit include:
- Patient participants 18 years and older
- Have an OUD-related diagnosis (e.g. Opioid Use Disorder in remission, Opioid Dependence, Opioid Abuse, Substance Use Disorder - opioids, etc.), or...
- Who meet at least one of the following criteria:
- Present to primary care at Central City Concern (CCC) within 8 weeks of starting or re-starting a treatment episode (defined as starting MOUD after...
You likely can't join if
- Patient participants who present for addiction treatment but are ineligible to receive on-going services at Central City (i.e. they have existing...
- Patient participants who are not able to verbally consent may not participate in the study.
- Patients who do not have addiction to opioids may not participate in the study.
- Patients who participated in Aim 2 would not be eligible for Aim 3
- Patients who lack stable phone access may not participate in the study.
See the full eligibility criteria
- Eligibility/. For Aim 3, criteria we seek to recruit include:
- Patient participants 18 years and older
- Have an OUD-related diagnosis (e.g. Opioid Use Disorder in remission, Opioid Dependence, Opioid Abuse, Substance Use Disorder - opioids, etc.), or have used fentanyl or heroin over the past 30 days
- Who meet at least one of the following criteria:
- Present to primary care at Central City Concern (CCC) within 8 weeks of starting or re-starting a treatment episode (defined as starting MOUD after not having received prescribed MOUD in an outpatient setting for OUD in...
- Who present to primary care at CCC and are not seeking treatment with MOUD and have not engaged in counseling services (e.g. harm reduction counseling) in the prior 30 days
- Have been receiving MOUD in prior 30 days but had a return to use (used fentanyl or heroin) within the past 30 days
- Medical complexity (e.g. self-reported or verified in patient's electronic health record)
- Have access to phone and/or computer for follow-up activities
- Desire to engage in counseling and/or peer services
- Patient participants who present for addiction treatment but are ineligible to receive on-going services at Central City (i.e. they have existing primary care at another location, or are currently receiving opioid use...
- Patient participants who are not able to verbally consent may not participate in the study.
- Patients who do not have addiction to opioids may not participate in the study.
- Patients who participated in Aim 2 would not be eligible for Aim 3
- Patients who lack stable phone access may not participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.